Tuesday, March 5, 2019

In Vitro interaction between yeast frataxin and superoxide dismutases: Influence of mitochondrial metals

›
Thi Hong Lien Han, Jean-Michel Camadro, Florent Barbault, Renata Santos, Jean-Michel El Hage Chahine, Nguyet-Thanh Ha-Duong; Biochimica et B...
Monday, March 4, 2019

Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia

›
Lynch, D. R., Hauser, L. , McCormick, A. , Wells, M. , Dong, Y. N., McCormack, S. , Schadt, K. , Perlman, S. , Subramony, S. H., Mathews, K....
Sunday, March 3, 2019

Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism

›
Nicholas G Fox, Xiaodi Yu, Xidong Feng, Henry J Bailey, Alain Martelli, Joseph F. Nabhan, Claire Strain-Damerell, Christine Bulawa, Wyatt W....
Friday, March 1, 2019

Researchers from Lleida make advances to propose new therapies in the treatment of Friedreich's ataxia

›
Communication and Press IRBLleida, February 28, the World Day of Minority Diseases. The Oxidative Stress Biochemical Research Group, of th...

C-Path, FARA launch Friedreich's Ataxia Clinical Database for Development of Treatments

›
EurekAlert, PUBLIC RELEASE: 27-FEB-2019, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 -- Critical Path Institute's (C-Path) Data Coll...
Wednesday, February 27, 2019

Minoryx recibe la aprobación de la Agencia Reguladora Española para iniciar el estudio de fase 2 en la ataxia de Friedreich

›
Mataró (Barcelona)-Charleroi (Bélgica), 27 de febrero de 2019. Minoryx Therapeutics, compañía biotecnológica especializada en el desarrollo ...

Minoryx Therapeutics lance une étude clinique de phase II dans l'ataxie de Friedreich avec l’autorisation de l'Agence Espagnole du Médicament

›
Mataró, Barcelone, Espagne et Charleroi, Belgique, le 27 février 2019 - Minoryx Therapeutics, une société spécialisée dans le développement...

Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia

›
Mataró, Barcelona, Spain and Charleroi, Belgium, February 27, 2019 - Minoryx Therapeutics, a company specializing in the development of new ...
Friday, February 22, 2019

Guidelines on the diagnosis and management of the progressive ataxias

›
Rajith de Silva, Julie Greenfield, Arron Cook, Harriet Bonney, Julie Vallortigara, Barry Hunt and Paola Giunti, Orphanet Journal of Rare Dis...
Thursday, February 21, 2019

The Role of Iron in Friedreich’s Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models

›
Llorens JV, Soriano S, Calap-Quintana P, Gonzalez-Cabo P and Moltó MD (2019). Front. Neurosci. 13:75. doi: 10.3389/fnins.2019.00075 we rev...